PharmNXT News

In an interaction with Thiruamuthan, Assistant Editor of India Pharma Outlook, Ankush Kapoor, Founder & CEO of PharmNXT Biotech, discusses how India’s biotech ecosystem is redefining bioprocessing through Single-Use Technologies, Defined Tubing Routing, and digital innovation. These advancements are enhancing scalability, sustainability, and compliance while significantly reducing energy, water use, and contamination risks. Startups are increasingly adopting modular, AI-driven, and continuous systems to overcome resource constraints, advance cell and gene therapy production, and position India as a global hub for efficient, sustainable, and technologically advanced biomanufacturing.

Pharma Industrial India Magazine – September – October

In a major boost to India’s biopharmaceutical manufacturing landscape, Pune-based startup PharmNXT Biotech has acquired Ireland-based Defined Tubing Routing (DTR), a globally recognised innovator in advanced bioprocess tubing solutions. The strategic acquisition gives PharmNXT direct access to cutting-edge technology in single-use systems, significantly enhancing its ability to deliver customised, high-compliance solutions for pharmaceutical and biopharma clients.

PharmNXT Biotech has acquired Defined Tubing Routing (DTR), a player from Ireland, working in advanced bioprocess tubing solutions. This move enables PharmNXT to access technology solutions related to single-use systems. With the addition of DTR’s modular tubing systems, capable of supporting bioprocess volumes from 20 L to 500 L and custom spans up to 2.9 meters, PharmNXT expands its engineering capabilities, faster turnaround, enhanced customisation, and stronger compliance. These systems aim to help reduce operational risks by minimising trip hazards and clearly outlining flow paths, thereby supporting safety and compliance.

This move enables PharmNXT to access technology solutions related to single-use systems, strengthening its capacity to serve pharmaceutical and biopharma clients with more tailored and technically aligned offerings. With the addition of DTR’s modular tubing systems, capable of supporting bioprocess volumes from 20 L to 500 L and custom spans up to 2.9 meters, PharmNXT significantly expands its engineering capabilities, faster turnaround, enhanced customisation, and stronger compliance.

As the Covid-19 pandemic swept across the globe, Indian vaccine makers faced an unexpected bottleneck—not in science or manpower, but in consumables. The single-use bags made of specialised plastic required for mixing and storing vaccine ingredients were in critically short supply. Global suppliers, including Sartorius, Cytiva, and Thermo Fisher, prioritised their home markets, leaving Indian manufacturers scrambling.

In a landmark development for India’s biopharmaceutical sector, PharmNXT Biotech has acquired Defined Tubing Routing (DTR), a globally recognised player from Ireland, working in advanced bioprocess tubing solutions. This move enables PharmNXT to access technology solutions related to single-use systems, strengthening its capacity to serve pharmaceutical and biopharma clients with more tailored and technically aligned offerings.

In an exclusive interview with Mr. Ankush Kapoor, Founder and CEO, and Mr. Sachin Joshi, Managing Director & Founder of PharmNXT Biotech, we explore the company’s remarkable journey in revolutionizing biopharma.

Union Minister of Finance and Corporate Affairs Nirmala Sitharaman presented the Union Budget 2025-26 in Parliament today, 1 February 2025. Laying emphasis on improving cancer care and treatment for millions in the country, the government has decided to set up Day Care Cancer Centres in all district hospitals in the next 3 years, with 200 centres coming up in 2025-26.

Union Minister of Finance and Corporate Affairs Nirmala Sitharaman on Saturday, during the presentation of the Union Budget, spoke about the establishment of daycare cancer centres and this was lauded by both, doctors and healthcare experts.

Ankush Kapoor was working with as large MNC as general manager, overseeing the commercial operations for India and South Asia, and promoting critical raw material used in pharma and biopharma industry was his forte. While Sachin Joshi was in the similar industry,